Advertisement

An update of the effect of far infrared therapy on arteriovenous access in end-stage renal disease patients

Abstract

The life qualities of end-stage renal disease (ESRD) patients rely largely on adequate dialysis, and a well-functioning vascular access is indispensable for high quality hemodialysis. Despite the advancement of surgical skills and the optimal maintenance of arteriovenous fistula (AVF), malfunction of AVF is still frequently encountered and has great impact on the life of ESRD patients. Several medical, mechanical and genetic prognostic factors are documented to affect the patency of AVF and arteriovenous graft (AVG). Heme oxygenase-1 (HO-1) is one of the genetic factors reported to play a role in cardiovascular disease and the patency of vascular access. Far infrared (FIR), a novel therapeutic modality, can not only conduct heat energy to AVF but also stimulate the non-thermal reactions mediated by HO-1. The use of FIR therapy significantly enhances the primary patency rate and maturation of AVF with fewer unfavorable adverse effects, and also achieves higher post-angioplasty patency rate for AVG. The only limitation in proving the effectiveness of FIR therapy in enhancing patency of AVF is that all the studies were conducted in Chinese people in Taiwan and thus, there is a lack of evidence and experience in people of other ethnicities.

J Vasc Access 2016; 17(4): 293 - 298

Article Type: REVIEW

DOI:10.5301/jva.5000561

Authors

Chun-Fan Chen, Wu-Chang Yang, Chih-Ching Lin

Article History

Disclosures

Financial support: This work was supported by intramural grants (V103C-043, V104C-026) from Taipei Veterans General Hospital, and the National Science Council (NSC101-2314-B010-024-MY3) and Ministry of Science and Technology (MOST 104-2314-B-010 -032 -MY3) in Taiwan.
Conflict of interest: None of the authors has financial interest related to this study to disclose.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Affiliations

  •  School of Medicine, National Yang-Ming University, Taipei - Taiwan
  •  Division of Nephrology, Department of Medicine, National Yang-Ming University Hospital, Yilan - Taiwan
  •  Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei - Taiwan

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.